Hypergendered Logic Source
Hypergendered Logic — Page 292
Appendix CA — Archgynocology/Archandrocology Professional Scope Core domains: Archendocrine measurement; receptor sensitivity assessment; pharmacological amount/sensitivity modulation; trajectory and jump modeling; ordinary womanhood/manhood interaction; phenotype monitoring; adaptation-load assessment; psychological/behavioural evaluation; social/relational context when clinically relevant; longitudinal follow-up; combination-regimen design; preference-sensitive decision making; prediction-error analysis; and research into missing causal variables. Professional standard: distinguish theorem from empirical effect; distinguish stage quality from patient wellbeing; obtain adequate trajectory history; model both concentration and sensitivity; avoid assuming maximal advancement is optimal; communicate uncertainty; update the model from observed response; and preserve the patient's own goals as a central optimization variable. Appendix CB — Proof-Status Matrix for the Medical Layer D: address bounds/mapping; gating; orthogonal amount-vs-sensitivity roles; noncarry/nonregression; axis-relative stagnation; notation/type distinctions. HI: prediction complexity, likely value of longitudinal provenance, likely importance of precision at high sensitivity. CD: exact timing/jump consequences of stipulated endocrine/pharmacological laws when antecedents are satisfied; exact clinical/phenotype effects only when explicit causal law exists. CI: possible overload/discomfort/regret, cross-axis interaction, tissue heterogeneity, context-sensitive wellbeing effects, developmental synchronization effects. ILL: elevator analogy, hypothetical patients, example phenotype trajectories. OPEN: exact sensitivity-to-ordinal functions; male hormone anatomical source; tissue-specific receptors; automatic lower-coordinate reset/carry rules (currently rejected by default); any additional bounded stage coordinate beyond Substage^3; exact major-Hyperstage phenotype constructor; PH-10 novelty. Appendix CC — Final Canonical Quick Reference: Archstage Endocrine Medicine GLOBAL ADDRESS = (Hyperstage, Stage, Substage, Substage^2, Substage^3). Hyperstage unbounded; other four coordinates <= Omega_H per Hyperstage. BASE CATEGORY MAP at H=S=U=0: U2=1 Supra, 2 Hyper, 3 Ultra, 4 Apex; U3=n gives superscript ^n. Raeyol/Halatorin -> Hyperstage. Alygorin/Gadoritin -> Stage. Operalin/Juegerin -> Substage. Zilanin/Vardorin -> Substage^2. Tolurarin/Nozadin -> Substage^3. AMOUNT -> TIME INTERVAL. RECEPTOR SENSITIVITY -> JUMP MAGNITUDE. Zero amount or zero receptor sensitivity -> no hormone-driven jump. Lowering/stopping drive does not erase attained stage. Hyperstage sensitivity/jump scale unbounded. Four lower coordinate jump effects capped by Omega_H. No automatic carry/reset. Requested large jump must satisfy target HGL closure prerequisites. Archgynocology/Archandrocology optimize individualized wellbeing and desired trajectory, not maximum speed or maximum stage. Psychological/social/relational/behavioural outcomes require causal/empirical bridge laws; they are not automatic stage theorems.
Source Canon: Verbatim mathematical and modal logic. Interactive navigation and operator lookups available at /#hgl-part:292.